97 related articles for article (PubMed ID: 15521978)
1. Health motivation and emotional vigilance in genetic testing for prostate cancer risk.
Li Y; Doukas DJ
Clin Genet; 2004 Dec; 66(6):512-6. PubMed ID: 15521978
[TBL] [Abstract][Full Text] [Related]
2. Attitudes and beliefs concerning prostate cancer genetic screening.
Doukas DJ; Localio AR; Li Y
Clin Genet; 2004 Nov; 66(5):445-51. PubMed ID: 15479190
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing intention to obtain a genetic test for colon cancer risk: a population-based study.
Bunn JY; Bosompra K; Ashikaga T; Flynn BS; Worden JK
Prev Med; 2002 Jun; 34(6):567-77. PubMed ID: 12052015
[TBL] [Abstract][Full Text] [Related]
4. Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing.
Cormier L; Valéri A; Azzouzi R; Fournier G; Cussenot O; Berthon P; Guillemin F; Mangin P
Prostate; 2002 Jun; 51(4):276-85. PubMed ID: 11987156
[TBL] [Abstract][Full Text] [Related]
5. How interested is the public in genetic testing for colon cancer susceptibility? Report of a cross-sectional population survey.
Graham ID; Logan DM; Hughes-Benzie R; Evans WK; Perras H; McAuley LM; Laupacis A; Stern H
Cancer Prev Control; 1998 Aug; 2(4):167-72. PubMed ID: 10093629
[TBL] [Abstract][Full Text] [Related]
6. Relation of family history of prostate cancer to perceived vulnerability and screening behavior.
Jacobsen PB; Lamonde LA; Honour M; Kash K; Hudson PB; Pow-Sang J
Psychooncology; 2004 Feb; 13(2):80-5. PubMed ID: 14872526
[TBL] [Abstract][Full Text] [Related]
7. Hereditary melanoma and predictive genetic testing: why not?
Riedijk SR; de Snoo FA; van Dijk S; Bergman W; van Haeringen A; Silberg S; van Elderen TM; Tibben A
Psychooncology; 2005 Sep; 14(9):738-45. PubMed ID: 15744786
[TBL] [Abstract][Full Text] [Related]
8. Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates.
Croyle RT; Lerman C
Prev Med; 1993 Mar; 22(2):284-92. PubMed ID: 8483865
[TBL] [Abstract][Full Text] [Related]
9. Likelihood of undergoing genetic testing for cancer risk: a population-based study.
Bosompra K; Flynn BS; Ashikaga T; Rairikar CJ; Worden JK; Solomon LJ
Prev Med; 2000 Feb; 30(2):155-66. PubMed ID: 10656843
[TBL] [Abstract][Full Text] [Related]
10. Interest, awareness, and perceptions of genetic testing among Hispanic family members of breast cancer survivors.
Ramirez AG; Aparicio-Ting FE; de Majors SS; Miller AR
Ethn Dis; 2006; 16(2):398-403. PubMed ID: 17682241
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
Davison BJ; Oliffe JL; Pickles T; Mroz L
Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
[TBL] [Abstract][Full Text] [Related]
12. Genetic testing for heart disease susceptibility: potential impact on motivation to quit smoking.
Sanderson SC; Michie S
Clin Genet; 2007 Jun; 71(6):501-10. PubMed ID: 17539899
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men's screening uptake.
Meiser B; Cowan R; Costello A; Giles GG; Lindeman GJ; Gaff CL
Urology; 2007 Oct; 70(4):738-42. PubMed ID: 17991547
[TBL] [Abstract][Full Text] [Related]
14. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
[TBL] [Abstract][Full Text] [Related]
15. Will genetic testing for complex diseases increase motivation to quit smoking? Anticipated reactions in a survey of smokers.
Sanderson SC; Wardle J
Health Educ Behav; 2005 Oct; 32(5):640-53. PubMed ID: 16148210
[TBL] [Abstract][Full Text] [Related]
16. The impact of information order on intentions to undergo predictive genetic testing: an experimental study.
Morrison V; Henderson BJ; Taylor C; A'Ch Dafydd N; Unwin A
J Health Psychol; 2010 Oct; 15(7):1082-92. PubMed ID: 20472604
[TBL] [Abstract][Full Text] [Related]
17. Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer.
Manne SL; Chung DC; Weinberg DS; Vig HS; Catts Z; Cabral MK; Shannon K; Meropol NJ
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2110-7. PubMed ID: 17932359
[TBL] [Abstract][Full Text] [Related]
18. Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
Macefield RC; Lane JA; Metcalfe C; Down L; Neal DE; Hamdy FC; Donovan JL
Eur J Cancer; 2009 Sep; 45(14):2569-73. PubMed ID: 19375907
[TBL] [Abstract][Full Text] [Related]
19. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide screen for prostate cancer susceptibility genes in men with clinically significant disease.
Chang BL; Isaacs SD; Wiley KE; Gillanders EM; Zheng SL; Meyers DA; Walsh PC; Trent JM; Xu J; Isaacs WB
Prostate; 2005 Sep; 64(4):356-61. PubMed ID: 15754351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
